The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Integrating multi-omics and reverse network toxicology to identify pollutant risks and potential intervention targets in pulmonary arterial hypertension
Abstract
Background: Idiopathic pulmonary arterial hypertension (PAH) is a progressive cardiovascular disorder with high mortality. Although both genetic and environmental factors are implicated in its pathogenesis, the underlying mechanisms remain unclear. Methods: We integrated transcriptomic data from PAH lung tissue, GWAS summary statistics, and QTL data for DNA methylation, gene expression, and plasma protein. Core dysregulated genes were first identified via differential expression and protein-protein interaction network analysis. Using summary-data-based Mendelian randomization (SMR), we systematically evaluated potential potential genetic associations between methylation, expression, or protein levels of candidate genes and PAH risk, with the HEIDI test to distinguish causality from pleiotropy. Key findings were validated by examining gene expression trends in two independent cohorts. Finally, reverse network toxicology was applied: environmental pollutants targeting identified genes were screened using the CTD, their binding potential assessed via molecular docking, and effects of a candidate pollutant on gene expression and cell proliferation validated in vitro in human pulmonary artery smooth muscle cells (HPASMCs). Results: We identified 254 differentially expressed genes in PAH. Among these, TAGLN2 exhibited a significant positive association with PAH risk at three molecular levels—DNA methylation, gene expression, and plasma protein, suggesting a pathogenic role. Specifically, increased TAGLN2 protein abundance (HR = 9.00, 95% CI: 1.52–53.16) and gene expression levels (HR = 9.00, 95% CI: 1.52–53.16) were associated with higher PAH risk, while its methylation sites (e.g., cg13892570, cg16107628) showed a negative association. Validation in two independent cohorts confirmed that TAGLN2 expression was upregulated in the lung tissue of PAH patients. Reverse toxicology predicted eight environmental pollutants as potential TAGLN2-targeting agents, including PFOS, dibutyl phthalate, bisphenols, and benzo[a]pyrene. Molecular docking indicated that all these compounds could bind stably to the TAGLN2 protein (binding free energy < −5.0 kcal/mol), with PFOS exhibiting the strongest binding affinity (−8.9 kcal/mol). In vitro experiments showed that PFOS upregulated TAGLN2 mRNA expression in HPASMCs and promoted cell proliferation in a dose-dependent manner, providing preliminary correlative evidence. Conclusion: This study prioritizes TAGLN2 as a genetically associated candidate gene for PAH and identifies environmental pollutants that may target TAGLN2. While the in vitro data show that PFOS upregulates TAGLN2 expression and promotes HPASMC proliferation, functional perturbation experiments are needed to establish a mechanistic requirement for TAGLN2. These findings provide hypothesis-generating insights into potential gene-environment interactions in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma proteomic associations with genetics and health in the UK Biobank
Sun, B. B., Chiou, J., Traylor, M., Benner, C., Hsu, Y.-H., Richardson, T. G., Surendran, P., Mahajan, A., Robins, C., Vasquez-Grinnell, S. G., et al. (2023) · Nature · doi:10.1038/s41586-023-06592-6 · Cited by 1,880
Research works printed but not linked: 32
- Banerjee, 2024, ProTox 3.0: a webserver for the prediction of toxicity of chemicals, Nucleic Acids Res., 52, W513, 10.1093/nar/gkae303 · DOI · Paper page
- Combes, 2019, Fine particle environmental pollution and cardiovascular diseases, Metabolism, 153944, 10.1016/j.metabol.2019.07.008 · DOI
- Evans, 2021, Endothelial cells in the pathogenesis of pulmonary arterial hypertension, Eur. Respir. J., 58, 2003957, 10.1183/13993003.03957-2020 · DOI · Paper page
- Fu, 2024, ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support, Nucleic Acids Res., 52, W422, 10.1093/nar/gkae236 · DOI · Paper page
- Huang, 2018, Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease, J. Cell Mol. Med., 22, 6249, 10.1111/jcmm.13912 · doi:10.1111/jcmm.13912
- Kan, 2017, Using omics approaches to understand pulmonary diseases, Respir. Res., 18, 149, 10.1186/s12931-017-0631-9 · DOI
- Kovacs, 2024, Definition, classification and diagnosis of pulmonary hypertension, Eur. Respir. J., 64, 2401324, 10.1183/13993003.01324-2024 · doi:10.1183/13993003.01324-2024
- Kurki, 2023, FinnGen provides genetic insights from a well-phenotyped isolated population, Nature, 613, 508, 10.1038/s41586-022-05473-8 · DOI · Paper page
- Lau, 2017, Epidemiology and treatment of pulmonary arterial hypertension, Nat. Rev. Cardiol., 14, 603, 10.1038/nrcardio.2017.84 · DOI · Paper page
- Lees-Miller, 1987, Isolation and characterization of an abundant and novel 22-kDa protein (SM22) from chicken gizzard smooth muscle, J. Biol. Chem., 262, 2988, 10.1016/S0021-9258(18)61457-7 · DOI
- Li, 2023, Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types, EBioMedicine, 88, 104432, 10.1016/j.ebiom.2022.104432 · DOI
- Long, 2025, RNA-seq and ChIP-seq reveal microplastics induce endothelial-mesenchymal transition via HK2-mediated histone lactylation in pulmonary hypertension, Vasc. Pharmacol., 162, 107571, 10.1016/j.vph.2025.107571 · DOI
- McRae, 2018, Identification of 55,000 replicated DNA Methylation QTL, Sci. Rep., 8, 17605, 10.1038/s41598-018-35871-w · DOI · Paper page
- Moutchia, 2024, Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis, Eur. Heart J., 45, 1937, 10.1093/eurheartj/ehae049 · DOI
- Münzel, 2025, Soil and water pollution and cardiovascular disease, Nat. Rev. Cardiol., 22, 71, 10.1038/s41569-024-01068-0 · DOI
- Naeije, 2022, The physiological basis of pulmonary arterial hypertension, Eur. Respir. J., 59, 2102334, 10.1183/13993003.02334-2021 · DOI · Paper page
- Olsson, 2023, Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management, Lancet Respir. Med., 11, 820, 10.1016/S2213-2600(23)00259-X · DOI
- Pan, 2023, Heterogeneity of treatment effects by risk in pulmonary arterial hypertension, Eur. Respir. J., 62, 2300190, 10.1183/13993003.00190-2023 · DOI
- Prattichizzo, 2024, Micro-nanoplastics and cardiovascular diseases: evidence and perspectives, Eur. Heart J., 45, 4099, 10.1093/eurheartj/ehae552 · DOI
- Qi, 2025, Exploring pesticide risk in autism via integrative machine learning and network toxicology, Ecotoxicol. Environ. Saf., 297, 118233, 10.1016/j.ecoenv.2025.118233 · DOI
- Ruopp, 2022, Diagnosis and treatment of pulmonary arterial hypertension: a review, JAMA, 327, 1379, 10.1001/jama.2022.4402 · DOI · Paper page
- Sofianopoulou, 2019, Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis, Eur. Respir. J., 53, 1801429, 10.1183/13993003.01429-2018 · DOI
- Võsa, 2021, Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression, Nat. Genet., 53, 1300, 10.1038/s41588-021-00913-z · DOI · Paper page
- Xu, 2025, Network toxicology and molecular docking to investigate the association of perfluorooctane sulfonate and pulmonary arterial hypertension via adverse outcome pathways, Ecotoxicol. Environ. Saf., 303, 119007, 10.1016/j.ecoenv.2025.119007 · DOI
- Yan, 2025, Decoding TAGLN2 in cancer: the molecular linchpin bridging actin remodeling, immune dysregulation and therapeutic challenges, Int. J. Biol. Macromol., 321, 146062, 10.1016/j.ijbiomac.2025.146062 · DOI
- Yin, 2019, Transgelin-2: biochemical and clinical implications in cancer and asthma, Trends Biochem. Sci., 44, 885, 10.1016/j.tibs.2019.05.004 · DOI
- Yue, 2026, Perfluorooctane sulfonate aggravates intimal hyperplasia and atherosclerosis by promoting phenotypic switching of smooth muscle cells via ERK/tPA pathway, J. Hazard Mater, 501, 140999, 10.1016/j.jhazmat.2025.140999 · DOI
- Zago, 2022, Pesticide exposure and risk of cardiovascular disease: a systematic review, Glob. Public Health, 17, 3944, 10.1080/17441692.2020.1808693 · DOI
- Zhang, 2014, Transgelin as a therapeutic target to prevent hypoxic pulmonary hypertension, Am. J. Physiol. Lung Cell Mol. Physiol., 306, L574, 10.1152/ajplung.00327.2013 · doi:10.1152/ajplung.00327.2013
- Zhou, 2022, Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt-related pulmonary arterial hypertension, Esc. Heart Fail, 9, 3407, 10.1002/ehf2.14080 · doi:10.1002/ehf2.14080
- Zhu, 2016, Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets, Nat. Genet., 48, 481, 10.1038/ng.3538 · DOI · Paper page
- Zhu, 2025, Multi-omics integrative analysis of the mechanisms linking environmental pollutant exposure to bladder cancer pathogenesis, Ecotoxicol. Environ. Saf., 305, 119251, 10.1016/j.ecoenv.2025.119251 · DOI
Metadata
- Authors
- You, S., Sun, Y., Li, N., Xie, H., Zeng, X., Su, X., liu, D., Shao, C., & Dai, A.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2026-06-05
- Volume
- 14
- ISSN
- 2296-634X
- Cited by
- 0
- References
- 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integrating multi-omics and reverse network toxicology to identify pollutant risks and potential intervention targets in pulmonary arterial hypertension. https://app.cochat.ai/papers/10.3389/fcell.2026.1840760
- The paper
- You, S., Sun, Y., Li, N., Xie, H., Zeng, X., Su, X., liu, D., Shao, C., & Dai, A. (2026). Integrating multi-omics and reverse network toxicology to identify pollutant risks and potential intervention targets in pulmonary arterial hypertension. Frontiers in Cell and Developmental Biology. https://doi.org/10.3389/fcell.2026.1840760
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.